(NYSE: LIN) LINDE's forecast annual revenue growth rate of 4.31% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.36%.
LINDE's revenue in 2022 is $31,761,000,000.On average, 5 Wall Street analysts forecast LIN's revenue for 2022 to be $16,801,231,925,702, with the lowest LIN revenue forecast at $16,445,761,046,246, and the highest LIN revenue forecast at $17,315,919,994,992. On average, 5 Wall Street analysts forecast LIN's revenue for 2023 to be $17,498,853,831,327, with the lowest LIN revenue forecast at $16,825,713,560,376, and the highest LIN revenue forecast at $18,154,462,787,784.
In 2024, LIN is forecast to generate $18,129,736,558,207 in revenue, with the lowest revenue forecast at $17,424,618,775,046 and the highest revenue forecast at $18,933,603,242,351.